BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29794103)

  • 1. Epidemiology of multimorbidity in New Zealand: a cross-sectional study using national-level hospital and pharmaceutical data.
    Stanley J; Semper K; Millar E; Sarfati D
    BMJ Open; 2018 May; 8(5):e021689. PubMed ID: 29794103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Pharmaceutical Dispensing-based Index of Mortality Risk From Long-term Conditions Performed as well as Hospital Record-based Indices.
    Stanley J; Doughty RN; Sarfati D
    Med Care; 2020 Feb; 58(2):e9-e16. PubMed ID: 31568163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of multimorbidity on people's lives: a cross-sectional survey.
    Stanley J; Millar E; Semper K; Davies C; Dowell A; Mangin D; Lawrenson R; Sarfati D
    N Z Med J; 2018 Jun; 131(1477):78-90. PubMed ID: 29927919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new measuring multimorbidity index predicted mortality better than Charlson and Elixhauser indices among the general population.
    Stanley J; Sarfati D
    J Clin Epidemiol; 2017 Dec; 92():99-110. PubMed ID: 28844785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimorbidity and multiple social disadvantage in a New Zealand high-needs free primary healthcare clinic population: a cross-sectional study.
    Sreedhar S; Richard L; Stokes T
    N Z Med J; 2019 Feb; 132(1490):42-51. PubMed ID: 30789888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethnic disparities in the quality of hospital care in New Zealand, as measured by 30-day rate of unplanned readmission/death.
    Rumball-Smith J; Sarfati D; Hider P; Blakely T
    Int J Qual Health Care; 2013 Jul; 25(3):248-54. PubMed ID: 23411833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Social disparities in the prevalence of multimorbidity - A register-based population study.
    Schiøtz ML; Stockmarr A; Høst D; Glümer C; Frølich A
    BMC Public Health; 2017 May; 17(1):422. PubMed ID: 28486983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of multimorbidity in the adult population attending primary care in Portugal: a cross-sectional study.
    Prazeres F; Santiago L
    BMJ Open; 2015 Sep; 5(9):e009287. PubMed ID: 26408832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity in Māori and Pacific patients: cross-sectional study in a Dunedin general practice.
    Stokes T; Azam M; Noble FD
    J Prim Health Care; 2018 Mar; 10(1):39-43. PubMed ID: 30068450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of in-hospital multimorbidity with healthcare outcomes in Swiss medical inpatients.
    Müller M; Huembelin M; Baechli C; Wagner U; Schuetz P; Mueller B; Kutz A
    Swiss Med Wkly; 2021 Feb; 151():w20405. PubMed ID: 33578431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Readmissions and postdischarge mortality by race and ethnicity among Medicare beneficiaries with multimorbidity.
    Wei MY; Cho J
    J Am Geriatr Soc; 2023 Jun; 71(6):1749-1758. PubMed ID: 36705464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of multimorbidity in Germany: impact of age and educational level in a cross-sectional study on 19,294 adults.
    Puth MT; Weckbecker K; Schmid M; Münster E
    BMC Public Health; 2017 Oct; 17(1):826. PubMed ID: 29047341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The most deprived Auckland City Hospital patients (2005-2009) are 10 years younger and have a 50% increased mortality following discharge from a cardiac or vascular admission when compared to the least deprived patients.
    Ellis C; Pryce A; Macleod G; Gamble G
    N Z Med J; 2012 Jun; 125(1357):15-35. PubMed ID: 22854358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimorbidity and use of hypnotic and anxiolytic drugs: cross-sectional and follow-up study in primary healthcare in Iceland.
    Linnet K; Gudmundsson LS; Birgisdottir FG; Sigurdsson EL; Johannsson M; Tomasdottir MO; Sigurdsson JA
    BMC Fam Pract; 2016 Jun; 17():69. PubMed ID: 27267943
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic and socioeconomic disparities in the prevalence of cardiovascular disease in New Zealand.
    Chan WC; Wright C; Riddell T; Wells S; Kerr AJ; Gala G; Jackson R
    N Z Med J; 2008 Nov; 121(1285):11-20. PubMed ID: 19079433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimorbidity prevalence and pattern in Indonesian adults: an exploratory study using national survey data.
    Hussain MA; Huxley RR; Al Mamun A
    BMJ Open; 2015 Dec; 5(12):e009810. PubMed ID: 26656028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of multimorbidity and its association with outcomes in older emergency general surgical patients: an observational study.
    Hewitt J; McCormack C; Tay HS; Greig M; Law J; Tay A; Asnan NH; Carter B; Myint PK; Pearce L; Moug SJ; McCarthy K; Stechman MJ
    BMJ Open; 2016 Mar; 6(3):e010126. PubMed ID: 27033960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variation in readmission and mortality following hospitalisation with a diagnosis of heart failure: prospective cohort study using linked data.
    Korda RJ; Du W; Day C; Page K; Macdonald PS; Banks E
    BMC Health Serv Res; 2017 Mar; 17(1):220. PubMed ID: 28320381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of physical conditions and multimorbidity in a cohort of adults with intellectual disabilities with and without Down syndrome: cross-sectional study.
    Kinnear D; Morrison J; Allan L; Henderson A; Smiley E; Cooper SA
    BMJ Open; 2018 Feb; 8(2):e018292. PubMed ID: 29431619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, correlates, and outcomes of multimorbidity among patients attending primary care in Odisha, India.
    Pati S; Swain S; Hussain MA; Kadam S; Salisbury C
    Ann Fam Med; 2015 Sep; 13(5):446-50. PubMed ID: 26371265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.